Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0XV2A
|
|||
Drug Name |
Benzylcinnamate
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H14O2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)COC(=O)C=CC2=CC=CC=C2
|
|||
InChI |
1S/C16H14O2/c17-16(12-11-14-7-3-1-4-8-14)18-13-15-9-5-2-6-10-15/h1-12H,13H2/b12-11+
|
|||
InChIKey |
NGHOLYJTSCBCGC-VAWYXSNFSA-N
|
|||
CAS Number |
CAS 103-41-3
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:146174
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Monoamine oxidase type B (MAO-B) | Target Info | Inhibitor | [1] |
Target's Patent Info | Monoamine oxidase type B (MAO-B) | Target's Patent Info | [1] | |
BioCyc | Superpathway of tryptophan utilization | |||
Tryptophan degradation via tryptamine | ||||
Dopamine degradation | ||||
Putrescine degradation III | ||||
Noradrenaline and adrenaline degradation | ||||
KEGG Pathway | Glycine, serine and threonine metabolism | |||
Arginine and proline metabolism | ||||
Histidine metabolism | ||||
Tyrosine metabolism | ||||
Phenylalanine metabolism | ||||
Tryptophan metabolism | ||||
Drug metabolism - cytochrome P450 | ||||
Metabolic pathways | ||||
Serotonergic synapse | ||||
Dopaminergic synapse | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
5-Hydroxytryptamine degredation | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
WikiPathways | Tryptophan metabolism | |||
Dopamine metabolism | ||||
Phase 1 - Functionalization of compounds |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):91-110. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.